A Phase 3, Multicenter, Open Label, Randomized Study Of Abarelix Versus Leuprolide Plus Daily Antiandrogen In Men With Prostate Cancer
Titel:
A Phase 3, Multicenter, Open Label, Randomized Study Of Abarelix Versus Leuprolide Plus Daily Antiandrogen In Men With Prostate Cancer
Auteur:
The Abarelix Study Group, Trachtenberg, John Gittleman, Marc Steidle, Christopher Barzell, Winston Friedel, William Pessis, Dennis Fotheringham, Nick Campion, Marilyn Garnick, Marc B.